Page last updated: 2024-09-05

dabigatran and Venous Thrombosis

dabigatran has been researched along with Venous Thrombosis in 135 studies

Research

Studies (135)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	19 (14.07)	29.6817
2010's	97 (71.85)	24.3611
2020's	19 (14.07)	2.80

Authors

Authors	Studies
Diao, XJ; Gong, GQ; He, GW; Xu, YG; Yang, WH; Yang, XZ	1
Alet, N; Altenburger, JM; Barre, G; Bocskei, Z; Bono, F; Briot, C; Dol, F; Florian, P; Follmann, M; Herault, JP; Herbert, JM; Klieber, S; Lassalle, G; Meneyrol, J; Millet, L; Petit, F; Rousseaux, T; Sadoun, F; Schaeffer, P; Schreuder, H; Wehner, V	1
Chen, D; Cui, S; Deng, X; Gong, G; Liu, J; Shi, J; Xu, Y; Yang, Y; Zhang, X; Zhu, Q	1
Biss, TT; Chalmers, EA	1
Boudot de la Motte, M; Daval, M; Deschamps, L; Deschamps, R; Diallo, IM; Nilles, C; Poillon, G	1
Fu, G; Liu, Z; Wang, Y; Yin, L; Zhang, K	1
Emmens, W; Mitrovic, D; Naimi, A; van den Bemt, P; van der Mijle, A; van Roon, E; Veeger, N	1
Hui, X; Li, J; Li, M; Ma, Y; Tian, J; Wang, Q; Wang, X; Xie, P; Yan, P; Yang, K; Yao, L	1
Chen, Y; Huang, K; Wu, M; Xia, H; Yu, S; Yu, W; Zhou, H	1
Alghamdi, B; Alhuwail, A; Alkhathami, S; Alkredees, M; Almalki, T; AlNasser, M; Alotaibi, W; Alqahtani, B; Alsaeed, O; Alsalem, T; Alshahrani, F; Alshreem, A; Alzahrani, Y; Asiri, A; Assiri, A; Ayoub, M; Bakkari, A; Basndwah, H; Ibrahim, ARN; Khudari, A; Mustafa, M; Sultan, H; Tawhari, F; Zaitoun, M	1
Alasheev, A; Canhão, P; Caria, J; Coutinho, JM; Dentali, F; Diener, HC; Ferro, JM; Frässdorf, M; Huisman, H; Karpov, D; Kobayashi, A; Nagel, S; Posthuma, L; Reilly, P; Roriz, JM	1
Choi, S; Hwang, KT; Jeong, SY; Koo, JW; Lee, JK; Park, KC	1
Ageno, W; Casella, IB; Chee, KH; Desch, M; Donado, E; Goldhaber, SZ; Reilly, PA; Schellong, S; Schulman, S; Singer, DE; Tang, W; Voccia, I	1
Bernelli, C; Danzi, GB; Olivotti, L; Paonessa, K	1
Bendszus, M; Caria, J; Coutinho, JM; Dentali, F; Diener, HC; Ferro, JM; Huisman, H; Jansen, O; Kobayashi, A; Miede, C; van der Veen, B	1
Hofmann, ER; Isaacs, DJ; Johnson, EJ; Rangarajan, S; Vinson, DR	1
Kenet, G	1
Conzen, KD; Stewart, E; Tran, TT; Williams, C; Wolf, S	1
Qu, R; Song, R; Wang, Y; Zhang, A; Zhou, D	1
Bose, G; Coutinho, J; Dowlatshahi, D; Fergusson, DA; Graveline, J; Le Gal, G; Mendonça, M; Nagel, S; Shorr, R; Viana-Baptista, M; Yogendrakumar, V	1
Aguiar de Sousa, D; Bendszus, M; Caria, J; Coutinho, JM; Dentali, F; Diener, HC; Ferro, JM; Huisman, H; Jansen, O; Kobayashi, A; Miede, C; Neto, LL	1
Jeon, SH; Kim, MS; Kwon, GH	1
Chen, YC; Hsu, PC; Lu, CC; Su, HM	1
Cifu, AS; Jain, A	1
Chenoweth, JA; Holmes, JF; Johnson, MA; Nishijima, DK; Shook, L; Sutter, ME	1
Albisetti, M; Biss, B; Bomgaars, L; Brueckmann, M; Gropper, S; Halton, JML; Harper, R; Huang, F; Luciani, M; Maas, H; Mitchell, LG; Tartakovsky, I	1
Avorn, J; Choudhry, NK; Gagne, JJ; Glynn, RJ; Krumme, AA; Kulldorff, M; Ortiz, AS; Pawar, A; Schneeweiss, S	1
Hu, Y; Tang, L; Zhang, Z	1
Fujino, T; Hamai, A; Hara, F; Harada, M; Ikeda, T; Kabuki, T; Ohara, H; Wakakura, S	1
Steurer, J	1
Caria, J; Coutinho, JM; Dentali, F; Desch, M; Diener, HC; Ferro, JM; Fraessdorf, M; Huisman, H; Kobayashi, A	1
Banica, A; Benoit, B; Delisle, J; Fernandes, JC; Laflamme, GY; Malo, M; Nguyen, H; Ranger, P; Senay, A; Trottier, M	1
Carrier, M; Khorana, AA; Lee, AYY; Meyer, G; Noble, S; O'Connell, C; Soff, G	1
Bawa, H; Dirschl, DR; Luu, HH; Weick, JW	1
Friedecky, D; Hlusi, A; Lukes, J; Nemcova, M; Palova, M; Prochazkova, J; Slavik, L; Ulehlova, J; Vaclavik, J; Zhanelova, M	1
Själander, A; Själander, S	1
Antropova, IP; Reino, EV; Yushkov, BG	1
Dibiasi, C; Gratz, J; Wiegele, M	1
Arcadi, FA; Calabrò, RS; Casella, C; Genovese, C; Giorgianni, R; Marino, S; Naro, A; Portaro, S	1
Hagihara, K; Ikeda, M; Iwanari, S; Nishikawa, S; Saita, H; Shimada, H; Shimoda, S; Takeoka, H; Tanaka, M; Taniguchi, K	1
Diao, XJ; Gong, GQ; He, GW; Li, F; Xu, YG; Yang, WH; Yang, XZ	1
Nieto Rodríguez, JA	1
Wanat, MA	1
Adam, SS; Lachiewicz, PF; McDuffie, JR; Ortel, TL; Williams, JW	1
Atar, D; Ghanima, W; Sandset, PM	1
Takeuchi, H	2
Barbar, S; Milan, M; Pesavento, R; Prandoni, P; Vedovetto, V	1
Degirmenci, SE; Steib, A	1
Wood, P	1
Baker, R; Herrmann, R; Muhammad, S; Phillips, M; Thom, J; Wood, A	1
Rondina, MT; Vazquez, S; Vo, T	1
Ansell, J; Mantha, S	1
Dickneite, G; Doerr, B; Herzog, E; Kaspereit, FJ; Krege, W; Pragst, I; van Ryn, J	1
Akwaa, F; Spyropoulos, AC	1
Black, DF; McBane, RD; Moder, KG; Schaefer, JK; Williams, LN; Wysokinski, WE	1
Feuerstein, JD; Ketwaroo, GA; Leffler, DA; Patwardhan, VR; Sengupta, N; Tapper, EB; Thaker, AM	1
Amin, A; Deitelzweig, S	1
Bultas, J; Karetová, D	1
Altın, C; Gezmiş, E; Müderrisoğlu, H; Sakallıoğlu, O	2
Barbosa, R; Calado, S; Cruz-e-Silva, V; Mendonça, MD; Viana-Baptista, M	1
Karahan, O	1
Karbyshev, IA; Petrikov, AS; Shoikhet, YN; Vyatkin, DA; Zakharchenko, KK	1
Fujino, T; Ikeda, T; Kabuki, T; Kiuchi, S; Kobayashi, K; Yamazaki, A; Yamazaki, J; Yamazaki, Y	1
Chen, Q; Dai, P; Gong, G; Wang, S; Xu, Y; Zhu, Q	1
Kesteven, P; McCaslin, JE; Robertson, L	2
Law, EH; Leung, TS	1
Altıntaş, F; Önal, A; Özler, T; Uluçay, Ç	1
Beinema, MJ; Brouwers, JR; Jansman, FG; Postma, MJ; Stevanović, J; van Leent, MW	1
Jugrin, AV; Lamotte, M; Sunderland, T; Urbich, M; Ustyugova, A	1
De Francesco, M; Hösel, V; Jugrin, AV; Lamotte, M; Sunderland, T; Ustyugova, A	1
Gross, PL; Ni, R; Saldanha, LJ; Shaya, SA; Vaezzadeh, N; Zhou, J	1
Bouget, J; Oger, E	1
Anto-Michel, N; Bode, C; Diehl, P; Geisen, U; Meyer, M; Moser, M; Olivier, CB; Weber, S; Weik, P; Zhou, Q	1
Roca, B; Roca, M	1
Stiefelhagen, P	1
Johnson, D; Northup, A; Senfield, J; Wiggins, BS	1
Ageno, W; Finazzi, G	1
Dobesh, PP; Finks, SW; Trujillo, TC	1
Arachchillage, DR; Baglin, T; Besser, M; Maclean, R; van Veen, JJ	1
Eriksson, H; Feuring, M; Fraessdorf, M; Goldhaber, SZ; Kakkar, A; Kreuzer, J; Schellong, S; Schulman, S	1
Anevlavis, S; Forest, F; Froudarakis, M; Karpathiou, G; Koulelidis, A; Voulgaris, T	1
Hansrani, V; Khanbhai, M; McCollum, C	1
Davies, AH; Lim, CS; Ravikumar, R	1
Ageno, W; Casella, IB; Desch, M; Goldhaber, SZ; Han, CK; Kimura, K; Raskob, GE; Schellong, S; Schulman, S; Singer, DE; Tang, W	1
Caldwell, SH; Intagliata, NM; Maitland, H; Pellitier, S	1
An, J; Garje, R; Leone, JP; Wanat, KA	1
Eriksson, H; Feuring, M; Goldhaber, SZ; Hantel, S; Kakkar, AJ; Kreuzer, J; Schellong, S; Schueler, E; Schulman, S	1
Cangemi, DJ; Cipher, DJ; Feagins, LA; Krill, T; Spechler, SJ; Weideman, R	1
Felix, SB; Greinacher, A; Hammer, F; Selleng, K; Wernicke, S	1
Ferrandis, R; Llau, JV; López Forte, C; Sapena, ML	1
Crain, EJ; Watson, CA; Wong, PC; Xin, B	1
Ageno, W; Dentali, F; Squizzato, A; Steidl, L	1
Apostolakis, S; Lip, GY; Shantsila, E	1
Becker, RC; Mackman, N	1
Lowenthal, DT; Sattari, M	1
Asencio, J; Garcia-Ortega, P	1
Alban, S; Völler, H; Westermann, D	1
Kwok, CS; Loke, YK	1
Dahl, OE; Eriksson, BI; Friedman, RJ; Hantel, S; Hermansson, K; Huo, MH; Kurth, AA; Schnee, JM	1
Meddahi, S; Samama, MM	1
Ageno, W; Prandoni, P	1
Beyer-Westendorf, J; Folprecht, G; Weiss, N; Werth, S	1
Arya, R; Patel, JP; Roberts, LN	1
Galanis, T; Kraft, WK; Merli, GJ	1
Büller, HR; Combe, S	1
Albaladejo, P; Rosencher, N	1
Cheng, PW; Hon, SF; Li, HL	1
Ataullakhanov, FI; Panteleev, MA; Sinauridze, EI	1
Amital, H; Furer, A; Karplus, R; Michael, L; Twig, G; Yaniv, G	1
Haas, S; Kreutz, R; Llau, J; Norrving, B; Turpie, AG	1
Esmon, CT	1
Fu, L; Jiang, F; Jin, Y; Liu, J; Liu, W; Zhang, Y	1
Lazo-Langner, A; Sun, D	1
Coccheri, S; Orlando, D	1
Jackiewicz, A; Krzemiński, M; Mrozik, D	1
Mungall, D	1
Gustafsson, D	1
Ahnfelt, L; Dahl, OE; Eriksson, BI; Hermansson, K; Kälebo, P; Kohlbrenner, V; Nehmiz, G; Stangier, J	1
Bates, SM; Weitz, JI	1
Büller, HR; Di Nisio, M; Middeldorp, S	1
Hampton, T	1
Liesenfeld, KH; Schäfer, HG; Stangier, J; Tillmann, C; Trocóniz, IF	1
Hauel, N; Priepke, H; Ries, UJ; Stassen, JM; Wienen, W	1
Ma, Q	1
Ieko, M	1
Büller, HR; Christiansen, AV; Dahl, OE; Eriksson, BI; Frostick, SP; Hantel, S; Hettiarachchi, R; Kälebo, P; Kurth, AA; Rosencher, N; Schnee, J; van Dijk, CN	1
Norrie, J	1
Büller, HR; Dahl, OE; Eriksson, BI; Frostick, SP; Hantel, S; Hettiarachchi, R; Kurth, AA; Prins, MH; Rosencher, N; Schnee, J; van Dijk, CN	1
Nendaz, M; Perrier, A	1

Reviews

34 review(s) available for dabigatran and Venous Thrombosis

Article	Year
Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis. The Cochrane database of systematic reviews, 2023, 04-14, Volume: 4 Topics: Anticoagulants; Antithrombins; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Neoplasm Recurrence, Local; Pulmonary Embolism; Rivaroxaban; Venous Thromboembolism; Venous Thrombosis	2023
Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review. BMJ open, 2021, 02-16, Volume: 11, Issue:2 Topics: Administration, Oral; Anticoagulants; Dabigatran; Hemorrhage; Humans; Venous Thrombosis	2021
Progress in the research on venous thromboembolism. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban, 2017, Volume: 37, Issue:6 Topics: Anticoagulants; Blood Coagulation Factors; Computed Tomography Angiography; Dabigatran; Genetic Predisposition to Disease; Heparin; Humans; Phlebography; Practice Guidelines as Topic; Pulmonary Embolism; Pyridines; Quality of Life; Recurrence; Risk Factors; Thiazoles; Venous Thromboembolism; Venous Thrombosis	2017
[New approaches in the treatment of deep vein thrombosis]. Medicina clinica, 2012, Volume: 139 Suppl 2 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Biotin; Clinical Trials, Phase III as Topic; Dabigatran; Drug Administration Schedule; Humans; Morpholines; Oligosaccharides; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Venous Thrombosis	2012
Novel oral anticoagulants: a review of new agents. Postgraduate medicine, 2013, Volume: 125, Issue:4 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Drug Administration Schedule; Humans; Morpholines; Postoperative Complications; Practice Guidelines as Topic; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2013
Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review. Annals of internal medicine, 2013, Aug-20, Volume: 159, Issue:4 Topics: Administration, Oral; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Comparative Effectiveness Research; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Heparin, Low-Molecular-Weight; Humans; Pulmonary Embolism; Venous Thromboembolism; Venous Thrombosis	2013
New oral anticoagulants--a review. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2013, Oct-01, Volume: 133, Issue:18 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Medication Adherence; Morpholines; Practice Guidelines as Topic; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2013
The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities. European journal of internal medicine, 2014, Volume: 25, Issue:1 Topics: Age Factors; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Dabigatran; Disease Management; Female; Fibrin Fibrinogen Degradation Products; Fibrinolytic Agents; Fondaparinux; Humans; Male; Morpholines; Obesity; Polysaccharides; Postthrombotic Syndrome; Pulmonary Embolism; Risk Assessment; Risk Factors; Rivaroxaban; Secondary Prevention; Sex Factors; Thiophenes; Thrombophilia; Ultrasonography; Venous Thromboembolism; Venous Thrombosis; Warfarin	2014
Current state of anticoagulants to treat deep venous thrombosis. Current cardiology reports, 2014, Volume: 16, Issue:3 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Medication Adherence; Morpholines; Patient Selection; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Thiophenes; Venous Thrombosis	2014
Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolism. Journal of thrombosis and thrombolysis, 2015, Volume: 39, Issue:2 Topics: Acute Disease; Adult; Aged; Anticoagulants; Clinical Trials, Phase III as Topic; Dabigatran; Female; Hemorrhage; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Recurrence; Risk Assessment; Rivaroxaban; Survival Analysis; Thiazoles; Venous Thrombosis	2015
The potential of target-specific oral anticoagulants for the acute and long-term treatment of venous thromboembolism. Current medical research and opinion, 2014, Volume: 30, Issue:11 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Heparin; Humans; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2014
Target-specific oral anticoagulants and the hospitalist. Hospital practice (1995), 2015, Volume: 43, Issue:1 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Clinical Trials, Phase III as Topic; Dabigatran; Factor Xa Inhibitors; Hospitalists; Humans; International Normalized Ratio; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Venous Thrombosis; Warfarin	2015
Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis. The Cochrane database of systematic reviews, 2015, Jun-30, Issue:6 Topics: Administration, Oral; Antithrombins; Azetidines; Benzylamines; Dabigatran; Factor Xa Inhibitors; Humans; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiazoles; Venous Thrombosis	2015
Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran. Drug design, development and therapy, 2015, Volume: 9 Topics: Anticoagulants; Antithrombins; Dabigatran; Hemorrhage; Humans; Pulmonary Embolism; Venous Thromboembolism; Venous Thrombosis	2015
Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism. The Cochrane database of systematic reviews, 2015, Dec-04, Issue:12 Topics: Administration, Oral; Anticoagulants; Antithrombins; Dabigatran; Factor Xa Inhibitors; Humans; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Recurrence; Rivaroxaban; Secondary Prevention; Thiazoles; Venous Thromboembolism; Venous Thrombosis	2015
The new oral anticoagulants: Reasonable alternatives to warfarin. Cleveland Clinic journal of medicine, 2015, Volume: 82, Issue:12 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Venous Thrombosis	2015
Management of Venous Thromboembolism: Recent Advances in Oral Anticoagulation Therapy. The Annals of pharmacotherapy, 2016, Volume: 50, Issue:6 Topics: Administration, Oral; Anticoagulants; Dabigatran; Drug Interactions; Humans; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiazoles; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis	2016
The Prevention of Venous Thromboembolism in Surgical Patients. Advances in experimental medicine and biology, 2017, Volume: 906 Topics: Age Factors; Anticoagulants; Communicable Diseases; Dabigatran; Dehydration; Fondaparinux; Heparin, Low-Molecular-Weight; Hormone Replacement Therapy; Humans; Neoplasms; Obesity; Polysaccharides; Primary Prevention; Pulmonary Embolism; Risk Factors; Surgical Procedures, Operative; Venous Thromboembolism; Venous Thrombosis	2017
The Role of New Oral Anticoagulants (NOACs) in Cancer Patients. Advances in experimental medicine and biology, 2017, Volume: 906 Topics: Administration, Oral; Anticoagulants; Antithrombins; Catheters, Indwelling; Dabigatran; Drug Administration Schedule; Drug Dosage Calculations; Humans; Neoplasms; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiazoles; Venous Thromboembolism; Venous Thrombosis	2017
[Anaesthesia and thromboembolic disease]. Medicina clinica, 2008, Volume: 131 Suppl 2 Topics: Acenocoumarol; Administration, Oral; Anesthesia, Conduction; Anticoagulants; Benzimidazoles; Clinical Protocols; Dabigatran; Early Ambulation; Fibrinolytic Agents; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; Morpholines; Polysaccharides; Postoperative Complications; Pyridines; Risk Factors; Rivaroxaban; Safety; Surgical Procedures, Operative; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2008
Novel oral anticoagulants in development: Dabigatran, Rivaroxaban, and Apixaban. American journal of therapeutics, 2011, Volume: 18, Issue:4 Topics: Administration, Oral; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Dabigatran; Drug Approval; Humans; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiophenes; United States; Venous Thrombosis	2011
[New oral anticoagulants: better than vitamin K antagonists?]. Der Internist, 2010, Volume: 51, Issue:12 Topics: Anticoagulants; Antithrombin Proteins; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Benzimidazoles; Dabigatran; Humans; Morpholines; Postoperative Complications; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiophenes; Venous Thrombosis; Vitamin K	2010
Dabigatran and rivaroxaban for prevention of venous thromboembolism--systematic review and adjusted indirect comparison. Journal of clinical pharmacy and therapeutics, 2011, Volume: 36, Issue:1 Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Enoxaparin; Factor Xa Inhibitors; Hemorrhage; Humans; Morpholines; Orthopedic Procedures; Postoperative Complications; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2011
Anticoagulating obese patients in the modern era. British journal of haematology, 2011, Volume: 155, Issue:2 Topics: Acute Coronary Syndrome; Anticoagulants; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Double-Blind Method; Factor Xa Inhibitors; Fondaparinux; Hemorrhage; Heparin; Humans; Morpholines; Multicenter Studies as Topic; Obesity; Polysaccharides; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Thiophenes; Thrombin; Thrombophilia; Venous Thrombosis; Warfarin	2011
Prophylaxis for deep vein thrombosis and pulmonary embolism in the surgical patient. Advances in surgery, 2011, Volume: 45 Topics: Anticoagulants; Arthroplasty, Replacement, Knee; Benzimidazoles; beta-Alanine; Dabigatran; Factor Xa Inhibitors; Heparin; Heparin, Low-Molecular-Weight; Humans; Intermittent Pneumatic Compression Devices; Morpholines; Neurosurgical Procedures; Orthopedic Procedures; Postoperative Complications; Pulmonary Embolism; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stockings, Compression; Surgical Procedures, Operative; Thiophenes; Urologic Surgical Procedures; Venous Thrombosis	2011
A new approach with anticoagulant development: tailoring anticoagulant therapy with dabigatran etexilate according to patient risk. Expert opinion on pharmacotherapy, 2012, Volume: 13, Issue:2 Topics: Anticoagulants; Benzimidazoles; Dabigatran; Hemorrhage; Humans; Orthopedic Procedures; Pyridines; Risk Factors; Venous Thromboembolism; Venous Thrombosis	2012
Anticoagulant therapy: basic principles, classic approaches and recent developments. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2012, Volume: 23, Issue:6 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Factor Xa; Factor Xa Inhibitors; Heparin, Low-Molecular-Weight; Hirudins; Humans; Platelet Aggregation Inhibitors; Thrombin; Thromboembolism; Thrombophilia; Venous Thrombosis; Vitamin K; Warfarin	2012
Management consensus guidance for the use of rivaroxaban--an oral, direct factor Xa inhibitor. Thrombosis and haemostasis, 2012, Volume: 108, Issue:5 Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Loss, Surgical; Clinical Trials as Topic; Dabigatran; Factor Xa Inhibitors; Female; Humans; Male; Morpholines; Practice Guidelines as Topic; Pregnancy; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism; Venous Thrombosis; Warfarin	2012
What did we learn from new oral anticoagulant treatment? Thrombosis research, 2012, Volume: 130 Suppl 1 Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation; Dabigatran; Drug Interactions; Factor Xa Inhibitors; Half-Life; Hemorrhage; Humans; Metabolic Clearance Rate; Morpholines; Rivaroxaban; Stroke; Thiophenes; Venous Thrombosis	2012
New oral anticoagulants in atrial fibrillation: a reappraisal of trial results looking at absolute figures. Internal and emergency medicine, 2013, Volume: 8, Issue:2 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Venous Thrombosis	2013
BIBR-1048 Boehringer Ingelheim. Current opinion in investigational drugs (London, England : 2000), 2002, Volume: 3, Issue:6 Topics: Animals; Benzimidazoles; Brain Ischemia; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Dabigatran; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinolytic Agents; Humans; Prodrugs; Pyridines; Structure-Activity Relationship; Thromboembolism; Venous Thrombosis	2002
Oral direct thrombin inhibitors in clinical development. Journal of internal medicine, 2003, Volume: 254, Issue:4 Topics: Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Dabigatran; Glycine; Hemostasis; Humans; Prodrugs; Pyridines; Stroke; Thrombin; Thrombosis; Venous Thrombosis; Vitamin K	2003
New anticoagulants. Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:8 Topics: Animals; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Blood Coagulation; Blood Coagulation Factors; Dabigatran; Factor IX; Fibrinolytic Agents; Humans; Models, Biological; Protein C; Pyridines; Thrombin; Thromboembolism; Venous Thrombosis	2005
Dabigatran etexilate, a thrombin inhibitor for the prevention of venous thromboembolism and stroke. Current opinion in investigational drugs (London, England : 2000), 2007, Volume: 8, Issue:9 Topics: Animals; Benzimidazoles; Dabigatran; Fibrinolytic Agents; Humans; Molecular Structure; Patents as Topic; Prodrugs; Pyridines; Stroke; Structure-Activity Relationship; Thrombin; Thromboembolism; Treatment Outcome; Venous Thrombosis	2007

Trials

13 trial(s) available for dabigatran and Venous Thrombosis

Article	Year
Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial. JAMA neurology, 2019, 12-01, Volume: 76, Issue:12 Topics: Adult; Aged; Anticoagulants; Antithrombins; Dabigatran; Female; Follow-Up Studies; Hemorrhage; Humans; Intracranial Thrombosis; Male; Middle Aged; Prospective Studies; Single-Blind Method; Treatment Outcome; Venous Thrombosis; Warfarin	2019
Comparison of the efficacy of rivaroxaban and dabigatran etexilate in preventing venous thrombosis after arthroplasty: A protocol of randomized controlled trial. Medicine, 2021, 01-08, Volume: 100, Issue:1 Topics: Administration, Oral; Antithrombins; Arthroplasty; Dabigatran; Humans; Postoperative Complications; Prospective Studies; Randomized Controlled Trials as Topic; Rivaroxaban; Treatment Outcome; Venous Thrombosis	2021
Recanalization after cerebral venous thrombosis. A randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous and dural sinus thrombosis. International journal of stroke : official journal of the International Stroke Society, 2022, Volume: 17, Issue:2 Topics: Anticoagulants; Cerebral Veins; Dabigatran; Humans; Prospective Studies; Sinus Thrombosis, Intracranial; Stroke; Treatment Outcome; Venous Thrombosis; Warfarin	2022
Phase IIa study of dabigatran etexilate in children with venous thrombosis: pharmacokinetics, safety, and tolerability. Journal of thrombosis and haemostasis : JTH, 2017, Volume: 15, Issue:11 Topics: Administration, Oral; Age Factors; Antithrombins; Blood Coagulation; Blood Coagulation Tests; Child; Child, Preschool; Dabigatran; Drug Compounding; Drug Monitoring; Female; Hemorrhage; Humans; Infant; Male; Pulmonary Embolism; Recurrence; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis	2017
Rationale, design, and protocol of a randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous thrombosis. International journal of stroke : official journal of the International Stroke Society, 2018, Volume: 13, Issue:7 Topics: Adult; Aged; Anticoagulants; Cerebral Veins; Clinical Trials, Phase III as Topic; Dabigatran; Dura Mater; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Venous Thrombosis; Warfarin; Young Adult	2018
Comparison of switch-therapy modalities (enoxaparin to rivaroxaban/dabigatran) and enoxaparin monotherapy after hip and knee replacement. Acta orthopaedica et traumatologica turcica, 2015, Volume: 49, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Dabigatran; Enoxaparin; Female; Hemorrhage; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Rivaroxaban; Ultrasonography, Doppler; Venous Thrombosis	2015
Indirect comparison and cost-utility of dabigatran etexilate and rivaroxaban in the treatment and extended anticoagulation of venous thromboembolism in a UK setting. Journal of medical economics, 2016, Volume: 19, Issue:1 Topics: Anticoagulants; Cost-Benefit Analysis; Dabigatran; Double-Blind Method; Female; Health Services; Hemorrhage; Humans; Male; Middle Aged; Models, Econometric; Pulmonary Embolism; Quality-Adjusted Life Years; Rivaroxaban; Venous Thromboembolism; Venous Thrombosis; Warfarin	2016
Treatment of acute pulmonary embolism with dabigatran versus warfarin. A pooled analysis of data from RE-COVER and RE-COVER II. Thrombosis and haemostasis, 2016, Sep-27, Volume: 116, Issue:4 Topics: Adult; Aged; Anticoagulants; Dabigatran; Female; Humans; Male; Middle Aged; Pulmonary Embolism; Venous Thromboembolism; Venous Thrombosis; Warfarin	2016
Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II). A randomised, double-blind, non-inferiority trial. Thrombosis and haemostasis, 2011, Volume: 105, Issue:4* Topics: Administration, Oral; Aged; Anticoagulants; Antithrombins; Arthroplasty, Replacement, Hip; Benzimidazoles; beta-Alanine; Dabigatran; Double-Blind Method; Enoxaparin; Female; Hemorrhage; Humans; Injections, Subcutaneous; Male; Middle Aged; Postoperative Complications; Survival Analysis; Venous Thromboembolism; Venous Thrombosis	2011
Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I. Journal of thrombosis and haemostasis : JTH, 2004, Volume: 2, Issue:9 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Benzimidazoles; Dabigatran; Dose-Response Relationship, Drug; Female; Hemorrhage; Humans; Male; Middle Aged; Prodrugs; Pyridines; Safety; Thrombin; Thromboembolism; Venous Thrombosis	2004
Population pharmacokinetic analysis of the new oral thrombin inhibitor dabigatran etexilate (BIBR 1048) in patients undergoing primary elective total hip replacement surgery. Journal of clinical pharmacology, 2007, Volume: 47, Issue:3 Topics: Administration, Oral; Aged; Algorithms; Anticoagulants; Arthroplasty, Replacement, Hip; Benzimidazoles; Chromatography, Liquid; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Elective Surgical Procedures; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Postoperative Complications; Pyridines; Software; Tablets; Tandem Mass Spectrometry; Venous Thrombosis	2007
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. Journal of thrombosis and haemostasis : JTH, 2007, Volume: 5, Issue:11 Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Benzimidazoles; Clinical Enzyme Tests; Dabigatran; Double-Blind Method; Drug Administration Routes; Enoxaparin; Follow-Up Studies; Hemorrhage; Humans; Middle Aged; Postoperative Complications; Prodrugs; Pyridines; Treatment Outcome; Venous Thrombosis	2007
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet (London, England), 2007, Sep-15, Volume: 370, Issue:9591 Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Benzimidazoles; Dabigatran; Double-Blind Method; Enoxaparin; Female; Hemorrhage; Humans; Male; Middle Aged; Postoperative Complications; Pyridines; Thromboembolism; Venous Thrombosis	2007

Other Studies

88 other study(ies) available for dabigatran and Venous Thrombosis

Article	Year
Synthesis and antithrombotic evaluation of novel dabigatran prodrugs containing a cleavable moiety with anti-platelet activity. European journal of medicinal chemistry, 2012, Volume: 57 Topics: Adenosine Diphosphate; Animals; Benzimidazoles; Blood Platelets; Dabigatran; Drug Design; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Microsomes, Liver; Platelet Aggregation; Platelet Aggregation Inhibitors; Prodrugs; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Pyrazines; Pyridines; Rabbits; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thrombin; Venous Thrombosis	2012
5-Chlorothiophene-2-carboxylic acid [(S)-2-[2-methyl-3-(2-oxopyrrolidin-1-yl)benzenesulfonylamino]-3-(4-methylpiperazin-1-yl)-3-oxopropyl]amide (SAR107375), a selective and potent orally active dual thrombin and factor Xa inhibitor. Journal of medicinal chemistry, 2013, Dec-12, Volume: 56, Issue:23 Topics: Animals; Anticoagulants; Crystallography, X-Ray; Drug Design; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Piperazines; Rats; Sulfonamides; Thrombin; Venous Thrombosis	2013
Design, synthesis and antithrombotic evaluation of novel non-peptide thrombin inhibitors. Bioorganic & medicinal chemistry, 2017, 01-15, Volume: 25, Issue:2 Topics: Animals; Dose-Response Relationship, Drug; Drug Design; Fibrinolytic Agents; Humans; Male; Molecular Structure; Platelet Aggregation; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thrombin; Venous Thrombosis	2017
Addendum to British Society for Haematology guideline on the investigation, management and prevention of venous thrombosis in children (Br. J. Haematol. 2011; 154: 196-207). British journal of haematology, 2021, Volume: 194, Issue:6 Topics: Anticoagulants; Child; Dabigatran; Disease Management; Humans; Rivaroxaban; Venous Thrombosis	2021
IgG4-related pachymeningitis and mastoiditis, associated with cerebral venous thrombosis: A case report. Journal of neuroimmunology, 2021, 11-15, Volume: 360 Topics: Abducens Nerve Diseases; Adrenal Cortex Hormones; Adult; Dabigatran; Female; Humans; Immunoglobulin G4-Related Disease; Lateral Sinus Thrombosis; Lung; Magnetic Resonance Imaging; Mastoidectomy; Mastoiditis; Meningitis; Neuroimaging; Rituximab; Thrombophilia; Tomography, X-Ray Computed; Venous Thrombosis	2021
Dabigatran Use after Argatroban for Heparin-induced Thrombocytopenia with Thrombosis: A Case Series and Literature Review. Annals of vascular surgery, 2022, Volume: 80 Topics: Aged; Anticoagulants; Antithrombins; Arginine; Dabigatran; Drug Therapy, Combination; Fatal Outcome; Female; Gastrointestinal Hemorrhage; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Count; Sulfonamides; Thrombocytopenia; Venous Thrombosis	2022
Thromboembolic Events While Taking Direct Oral Anticoagulants: An Analysis of Post-market WHO Database Reports from 2012 to 2020. Clinical drug investigation, 2022, Volume: 42, Issue:7 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Dabigatran; Humans; Pulmonary Embolism; Pyridones; Reproducibility of Results; Rivaroxaban; Venous Thromboembolism; Venous Thrombosis; World Health Organization	2022
Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis. BMC gastroenterology, 2023, Sep-25, Volume: 23, Issue:1 Topics: Administration, Oral; Anticoagulants; Dabigatran; End Stage Liver Disease; Hemorrhage; Humans; Liver Cirrhosis; Portal Vein; Retrospective Studies; Rivaroxaban; Severity of Illness Index; Treatment Outcome; Venous Thrombosis	2023
Utilization of direct oral anticoagulants in a Saudi tertiary hospital: a retrospective cohort study. European review for medical and pharmacological sciences, 2023, Volume: 27, Issue:20 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Humans; Male; Middle Aged; Pulmonary Embolism; Retrospective Studies; Rivaroxaban; Saudi Arabia; Stroke; Tertiary Care Centers; Venous Thrombosis	2023
Perioperative symptomatic venous thromboembolism after immediate chemoprophylaxis in patients with pelvic and lower-extremity fractures. Scientific reports, 2020, 03-25, Volume: 10, Issue:1 Topics: Adult; Aged; Anticoagulants; Bones of Lower Extremity; Chemoprevention; Dabigatran; Enoxaparin; Female; Fractures, Bone; Humans; Male; Middle Aged; Multidetector Computed Tomography; Pelvic Bones; Pulmonary Embolism; Risk Factors; Sex Factors; Venous Thromboembolism; Venous Thrombosis; Young Adult	2020
Profile of Patients Diagnosed With Acute Venous Thromboembolism in Routine Clinical Practice: The RE-COVERY DVT/PE™ Study. The American journal of medicine, 2020, Volume: 133, Issue:8 Topics: Administration, Oral; Adult; Age Distribution; Aged; Anticoagulants; Asia; Comorbidity; Cross-Sectional Studies; Dabigatran; Diabetes Mellitus; Europe; Factor Xa Inhibitors; Female; Fondaparinux; Heparin; Humans; Hypertension; Latin America; Male; Middle Aged; Middle East; Neoplasms; Postoperative Complications; Practice Patterns, Physicians'; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Venous Thromboembolism; Venous Thrombosis; Wounds and Injuries	2020
Pulmonary vein thrombosis in a patient undergoing anticoagulation treatment: an intriguing clinical diagnosis. Journal of cardiovascular medicine (Hagerstown, Md.), 2020, Volume: 21, Issue:6 Topics: Administration, Oral; Anticoagulants; Antithrombins; Atrial Fibrillation; Cardiac Surgical Procedures; Dabigatran; Drug Substitution; Female; Humans; Middle Aged; Pulmonary Veins; Pulmonary Veno-Occlusive Disease; Treatment Outcome; Vascular System Injuries; Venous Thrombosis; Warfarin	2020
Dural Arteriovenous Fistulae After Cerebral Venous Thrombosis. Stroke, 2020, Volume: 51, Issue:11 Topics: Adult; Anticoagulants; Antithrombins; Arteriovenous Fistula; Central Nervous System Vascular Malformations; Cerebral Angiography; Cerebral Veins; Cranial Sinuses; Dabigatran; Female; Humans; Imaging, Three-Dimensional; Intracranial Thrombosis; Magnetic Resonance Angiography; Male; Meningeal Arteries; Middle Aged; Randomized Controlled Trials as Topic; Secondary Prevention; Sinus Thrombosis, Intracranial; Venous Thrombosis; Warfarin	2020
Primary care physicians comprehensively manage acute pulmonary embolism without higher-level-of-care transfer: A report of two cases. Medicine, 2020, Nov-06, Volume: 99, Issue:45 Topics: Acute Disease; Adult; Ambulatory Care; Anticoagulants; Antithrombins; Chest Pain; Computed Tomography Angiography; Dabigatran; Decision Making, Shared; Dyspnea; Enoxaparin; Hospitalization; Humans; Male; Middle Aged; Myelitis, Transverse; Patient Transfer; Physicians, Primary Care; Pulmonary Embolism; Risk Assessment; Treatment Outcome; Venous Thrombosis	2020
Dabigatran etexilate and treatment of acute venous thromboembolism in children. The Lancet. Haematology, 2021, Volume: 8, Issue:1 Topics: Anticoagulants; Child; Dabigatran; Humans; Venous Thromboembolism; Venous Thrombosis	2021
Dabigatran Reversal With Idarucizumab in 2 Patients With Portal Vein Thrombosis Undergoing Orthotopic Liver Transplantation. Seminars in cardiothoracic and vascular anesthesia, 2021, Volume: 25, Issue:3 Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Anticoagulants; Dabigatran; Humans; Liver Transplantation; Male; Portal Vein; Venous Thrombosis	2021
Symptomatic bilateral massive pulmonary embolism and proximal and distal deep vein thrombosis following arthroscopic meniscus surgery: A case report. Medicine, 2021, Apr-02, Volume: 100, Issue:13 Topics: Adult; Anticoagulants; Arthroscopy; Dabigatran; Electrocardiography; Femoral Vein; Heparin, Low-Molecular-Weight; Humans; Male; Meniscus; Popliteal Vein; Postoperative Complications; Pulmonary Artery; Pulmonary Embolism; Tomography, X-Ray Computed; Treatment Outcome; Venous Thrombosis	2021
Unilateral extensive purpura resulting from chronic iliofemoral deep venous thrombosis successfully treated by endovascular therapy with iliac vein stenting. The Kaohsiung journal of medical sciences, 2021, Volume: 37, Issue:10 Topics: Antithrombins; Dabigatran; Endovascular Procedures; Humans; Iliac Vein; Male; Middle Aged; Stents; Venous Thrombosis	2021
Antithrombotic Therapy for Venous Thromboembolic Disease. JAMA, 2017, 05-16, Volume: 317, Issue:19 Topics: Antithrombins; Dabigatran; Humans; Practice Guidelines as Topic; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Review Literature as Topic; Rivaroxaban; Thiazoles; Venous Thromboembolism; Venous Thrombosis; Vitamin K	2017
Prevalence of Intracranial Hemorrhage after Blunt Head Trauma in Patients on Pre-injury Dabigatran. The western journal of emergency medicine, 2017, Volume: 18, Issue:5 Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Dabigatran; Female; Head Injuries, Closed; Hospitals, University; Humans; Intracranial Hemorrhage, Traumatic; Male; Middle Aged; Prevalence; Pulmonary Embolism; Retrospective Studies; Stroke; Tomography, X-Ray Computed; Trauma Centers; Urban Population; Venous Thrombosis	2017
Study protocol for the dabigatran, apixaban, rivaroxaban, edoxaban, warfarin comparative effectiveness research study. Journal of comparative effectiveness research, 2018, Volume: 7, Issue:1 Topics: Anticoagulants; Antithrombins; Comparative Effectiveness Research; Dabigatran; Factor Xa Inhibitors; Humans; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Research Design; Rivaroxaban; Thiazoles; Venous Thrombosis; Warfarin	2018
Comparison of Direct Oral Anticoagulants and Warfarin in the Treatment of Deep Venous Thrombosis in the Chronic Phase. International heart journal, 2018, Jan-27, Volume: 59, Issue:1 Topics: Administration, Oral; Aged; Anticoagulants; Antithrombins; Chronic Disease; Dabigatran; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Female; Humans; Male; Pyrazoles; Pyridines; Pyridones; Recurrence; Thiazoles; Treatment Outcome; Ultrasonography; Venous Thrombosis; Warfarin	2018
Praxis, 2018, Volume: 107, Issue:3 Topics: Anticoagulants; Antithrombins; Clinical Trials as Topic; Dabigatran; Hemorrhage; Pulmonary Embolism; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Survival Analysis; Venous Thrombosis; Warfarin	2018
Incidence of symptomatic venous thromboembolism in 2372 knee and hip replacement patients after discharge: data from a thromboprophylaxis registry in Montreal, Canada. Vascular health and risk management, 2018, Volume: 14 Topics: Aged; Anticoagulants; Antithrombins; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Dabigatran; Enoxaparin; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Patient Discharge; Pulmonary Embolism; Quebec; Registries; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis	2018
Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH. Journal of thrombosis and haemostasis : JTH, 2018, Volume: 16, Issue:9 Topics: Administration, Oral; Anticoagulants; Antithrombins; Dabigatran; Dalteparin; Factor Xa Inhibitors; Hemorrhage; Humans; Multicenter Studies as Topic; Neoplasms; Observational Studies as Topic; Patient Acceptance of Health Care; Prospective Studies; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Recurrence; Rivaroxaban; Thiazoles; Venous Thromboembolism; Venous Thrombosis	2018
Trends in Deep Vein Thrombosis Prophylaxis and Deep Vein Thrombosis Rates After Total Hip and Knee Arthroplasty. The Journal of the American Academy of Orthopaedic Surgeons, 2018, Oct-01, Volume: 26, Issue:19 Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Clinical Decision-Making; Dabigatran; Databases, Factual; Enoxaparin; Female; Fondaparinux; Humans; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Rivaroxaban; Venous Thrombosis; Warfarin	2018
Multianalyte Determination of NOACs Using LC-MS/MS and Comparison with Functional Coagulation Assays. Clinical laboratory, 2018, Oct-01, Volume: 64, Issue:10 Topics: Administration, Oral; Anticoagulants; Blood Coagulation; Blood Coagulation Tests; Chromatography, Liquid; Dabigatran; Factor Xa Inhibitors; Humans; Partial Thromboplastin Time; Prothrombin Time; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Tandem Mass Spectrometry; Thrombin; Venous Thrombosis	2018
Lakartidningen, 2018, 12-04, Volume: 115 Topics: Anticoagulants; Antithrombins; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Neoplasms; Perioperative Care; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Venous Thromboembolism; Venous Thrombosis	2018
[The clotting tests and molecular markers in evaluating of coagulation alterations against the background of anti-thrombotic prevention by Dabigatran after large orthopedic operations]. Klinicheskaia laboratornaia diagnostika, 2017, Volume: 62, Issue:1 Topics: Anticoagulants; Arthroplasty, Replacement, Knee; Blood Coagulation; Blood Coagulation Tests; Dabigatran; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinopeptide A; Humans; Knee Joint; Male; Middle Aged; Postoperative Complications; Thrombin; Venous Thrombosis	2017
Orthotopic liver transplantation in a patient receiving apixaban for portal vein thrombosis. Journal of clinical anesthesia, 2019, Volume: 56 Topics: Aged; Blood Loss, Surgical; Carcinoma, Hepatocellular; Dabigatran; Humans; Infusions, Intravenous; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Mesenteric Vascular Occlusion; Mesenteric Veins; Pyrazoles; Pyridones; Risk Assessment; Thromboembolism; Tranexamic Acid; Venous Thrombosis	2019
New versus Old Oral Anticoagulants: How Can We Set the Scale Needle? Considerations on a Case Report. Medicina (Kaunas, Lithuania), 2019, Mar-17, Volume: 55, Issue:3 Topics: Abortion, Spontaneous; Acenocoumarol; Adult; Antiphospholipid Syndrome; Antithrombins; Carotid Arteries; Computed Tomography Angiography; Dabigatran; Female; Follow-Up Studies; Humans; Product Surveillance, Postmarketing; Pulmonary Embolism; Stroke; Treatment Outcome; Venous Thrombosis; Warfarin	2019
Dabigatran-induced anticoagulant-related nephropathy with undiagnosed IgA nephropathy in a patient with normal baseline renal function. CEN case reports, 2019, Volume: 8, Issue:4 Topics: Acute Kidney Injury; Aged; Anticoagulants; Dabigatran; Female; Glomerulonephritis, IGA; Hematuria; Humans; Kidney Glomerulus; Venous Thrombosis; Withholding Treatment	2019
Dabigatran "non-inferior" to warfarin, but only just. BMJ (Clinical research ed.), 2013, Feb-27, Volume: 346 Topics: Administration, Oral; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Humans; Pulmonary Embolism; Treatment Outcome; Venous Thrombosis; Warfarin	2013
Design, synthesis and antithrombotic evaluation of novel dabigatran prodrugs containing methyl ferulate. Bioorganic & medicinal chemistry letters, 2013, Apr-01, Volume: 23, Issue:7 Topics: Benzimidazoles; beta-Alanine; Caffeic Acids; Dabigatran; Dose-Response Relationship, Drug; Drug Design; Fibrinolytic Agents; Humans; Molecular Structure; Platelet Aggregation; Platelet Aggregation Inhibitors; Prodrugs; Pyridines; Thrombin; Venous Thrombosis	2013
Floating thrombus in the left upper pulmonary vein dissolved by dabigatran. BMJ case reports, 2013, Oct-09, Volume: 2013 Topics: Aged; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Diagnosis, Differential; Echocardiography, Transesophageal; Follow-Up Studies; Humans; Male; Multidetector Computed Tomography; Pulmonary Veins; Venous Thrombosis	2013
[New direct oral anticoagulants and venous thromboprophylaxis]. La Revue du praticien, 2013, Volume: 63, Issue:7 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Venous Thrombosis	2013
New oral anticoagulants: an emergency department overview. Emergency medicine Australasia : EMA, 2013, Volume: 25, Issue:6 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Australia; Benzimidazoles; beta-Alanine; Dabigatran; Emergency Service, Hospital; Humans; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Venous Thrombosis	2013
Thrombin generation using the calibrated automated thrombinoscope to assess reversibility of dabigatran and rivaroxaban. Thrombosis and haemostasis, 2014, May-05, Volume: 111, Issue:5 Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Automation, Laboratory; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Dabigatran; Equipment and Supplies; Factor VII; Hemorrhage; Humans; Morpholines; Postoperative Complications; Rivaroxaban; Stroke; Thiophenes; Thrombelastography; Thrombin; Thrombin Time; Venous Thrombosis; Withholding Treatment	2014
Chest pain caused by pulmonary vein thrombi could be curable by dabigatran. BMJ case reports, 2014, Mar-13, Volume: 2014 Topics: Aged; Antithrombins; Benzimidazoles; beta-Alanine; Chest Pain; Dabigatran; Humans; Male; Multidetector Computed Tomography; Pulmonary Veins; Venous Thrombosis	2014
Thrombotic safety of prothrombin complex concentrate (Beriplex P/N) for dabigatran reversal in a rabbit model. Thrombosis research, 2014, Volume: 134, Issue:3 Topics: Animals; Blood Coagulation; Blood Coagulation Tests; Dabigatran; Disease Models, Animal; Drug Combinations; Factor IX; Factor VII; Factor X; Female; Hemorrhage; Hemostatics; Prothrombin; Rabbits; Risk Assessment; Risk Factors; Thrombin; Time Factors; Venous Thrombosis	2014
Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients. Thrombosis and haemostasis, 2014, Volume: 112, Issue:5 Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Benzimidazoles; beta-Alanine; Cerebral Infarction; Dabigatran; Drug Substitution; Female; Humans; International Normalized Ratio; Lupus Erythematosus, Systemic; Male; Mesenteric Veins; Middle Aged; Morpholines; Portal Vein; Recurrence; Retrospective Studies; Rivaroxaban; Splenic Vein; Stroke; Thiophenes; Thromboembolism; Thrombophilia; Treatment Failure; Venous Thrombosis; Warfarin	2014
The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study. The American journal of gastroenterology, 2015, Volume: 110, Issue:2 Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Enoxaparin; Female; Gastrointestinal Hemorrhage; Heparin; Humans; Ischemic Attack, Transient; Longitudinal Studies; Male; Middle Aged; Morpholines; Patient Readmission; Prospective Studies; Pulmonary Embolism; Pyrazoles; Pyridones; Recurrence; Rivaroxaban; Stroke; Thiophenes; Thromboembolism; Venous Thrombosis; Warfarin; Withholding Treatment	2015
[Extended options of anticoagulant treatment in thromboembolism]. Vnitrni lekarstvi, 2014, Volume: 60, Issue:11 Topics: Administration, Oral; Aged; Antithrombins; Benzimidazoles; beta-Alanine; Czech Republic; Dabigatran; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Pulmonary Embolism; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism; Venous Thrombosis	2014
A novel oral anticoagulant, dabigatran, in acute renal infarction. Anatolian journal of cardiology, 2015, Volume: 15, Issue:2 Topics: Anticoagulants; Cardiac Catheterization; Cardiomyopathy, Dilated; Dabigatran; Diagnosis, Differential; Humans; Kidney Diseases; Male; Middle Aged; Tomography, X-Ray Computed; Venous Thrombosis	2015
Oral direct thrombin inhibitor as an alternative in the management of cerebral venous thrombosis: a series of 15 patients. International journal of stroke : official journal of the International Stroke Society, 2015, Volume: 10, Issue:7 Topics: Administration, Oral; Adult; Aged; Antithrombins; Dabigatran; Female; Humans; Intracranial Thrombosis; Magnetic Resonance Imaging; Male; Middle Aged; Retrospective Studies; Tomography, X-Ray Computed; Treatment Outcome; Venous Thrombosis; Young Adult	2015
Possible renoprotective effects of dabigatran. Anatolian journal of cardiology, 2015, Volume: 15, Issue:6 Topics: Anticoagulants; Dabigatran; Humans; Kidney Diseases; Male; Venous Thrombosis	2015
[Use of dabigatran etexilate for treatment of deep vein thrombosis and pulmonary artery thromboembolism]. Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery, 2015, Volume: 21, Issue:2 Topics: Adult; Angiography; Benzimidazoles; Blood Coagulation; Dabigatran; Dose-Response Relationship, Drug; Echocardiography; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Prodrugs; Prospective Studies; Pulmonary Embolism; Pyridines; Russia; Thrombophilia; Treatment Outcome; Venous Thrombosis	2015
Efficacy of Dabigatran for Dissolving Deep Vein Thromboses in Outpatients With a Deteriorated General Condition. International heart journal, 2015, Volume: 56, Issue:4 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Health Status Disparities; Humans; Japan; Male; Middle Aged; Neoplasms; Outpatients; Severity of Illness Index; Stroke; Treatment Outcome; Ultrasonography; Venous Thrombosis	2015
Design, Synthesis, and Biological Evaluation of Dabigatran Etexilate Mimics, a Novel Class of Thrombin Inhibitors. Archiv der Pharmazie, 2015, Volume: 348, Issue:8 Topics: Animals; Antithrombins; Binding Sites; Crystallography, X-Ray; Dabigatran; Disease Models, Animal; Drug Design; Hemorrhage; Humans; Ligands; Mice; Molecular Docking Simulation; Molecular Mimicry; Platelet Aggregation; Protein Binding; Protein Conformation; Rabbits; Rats; Rats, Sprague-Dawley; Risk Assessment; Structure-Activity Relationship; Thrombin; Venous Thrombosis	2015
Cost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World Data. PloS one, 2015, Volume: 10, Issue:8 Topics: Anticoagulants; Antithrombins; Cost Savings; Cost-Benefit Analysis; Dabigatran; Decision Support Techniques; Health Resources; Humans; Netherlands; Pulmonary Embolism; Quality-Adjusted Life Years; Retrospective Studies; Venous Thrombosis; Vitamin K	2015
Author's reply. Anatolian journal of cardiology, 2015, Volume: 15, Issue:6 Topics: Anticoagulants; Dabigatran; Humans; Kidney Diseases; Male; Venous Thrombosis	2015
The cost-utility of dabigatran etexilate compared with warfarin in treatment and extended anticoagulation of acute VTE in the UK. Thrombosis and haemostasis, 2015, Volume: 114, Issue:4 Topics: Acute Disease; Anticoagulants; Cost-Benefit Analysis; Dabigatran; Drug Administration Schedule; Drug Costs; Hemorrhage; Humans; Kaplan-Meier Estimate; Models, Economic; Pulmonary Embolism; Quality-Adjusted Life Years; State Medicine; Time Factors; Treatment Outcome; United Kingdom; Venous Thromboembolism; Venous Thrombosis; Warfarin	2015
Dabigatran (Pradaxa): deep vein thrombosis and pulmonary embolism. Warfarin remains the standard drug. Prescrire international, 2015, Volume: 24, Issue:161 Topics: Administration, Oral; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Coagulation Tests; Dabigatran; Drug Monitoring; Hemorrhage; Humans; Pulmonary Embolism; Risk Assessment; Risk Factors; Treatment Outcome; Venous Thrombosis; Warfarin	2015
Comparison of the effect of dabigatran and dalteparin on thrombus stability in a murine model of venous thromboembolism. Journal of thrombosis and haemostasis : JTH, 2016, Volume: 14, Issue:1 Topics: Animals; Anticoagulants; Antithrombins; Dabigatran; Dalteparin; Disease Models, Animal; Disease Progression; Embolization, Therapeutic; Female; Femoral Vein; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Lung; Mice; Mice, Inbred C57BL; Microscopy, Video; Pulmonary Embolism; Thrombosis; Venous Thromboembolism; Venous Thrombosis	2016
Emergency admissions for major haemorrhage associated with direct oral anticoagulants. Thrombosis research, 2015, Volume: 136, Issue:6 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Emergency Service, Hospital; Female; Gastrointestinal Hemorrhage; Hemodynamics; Hemorrhage; Hemostasis; Humans; Intracranial Hemorrhages; Male; Middle Aged; Patient Admission; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Venous Thrombosis	2015
TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran. Thrombosis research, 2016, Volume: 138 Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Blood Platelets; Dabigatran; Female; Humans; Male; Middle Aged; Platelet Aggregation; Pulmonary Embolism; Receptors, Thrombin; Rivaroxaban; Venous Thrombosis	2016
[Your patient needs an antithrombotic drug. Venous thrombosis of the leg: how and how long anticoagulation?]. MMW Fortschritte der Medizin, 2015, Oct-08, Volume: 157, Issue:17 Topics: Administration, Oral; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Substitution; Fibrinolytic Agents; General Practice; Heparin, Low-Molecular-Weight; Humans; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Thiazoles; Venous Thrombosis	2015
Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant Phenytoin. Pharmacotherapy, 2016, Volume: 36, Issue:2 Topics: Anticonvulsants; Antithrombins; Dabigatran; Drug Interactions; Drug Monitoring; Humans; Male; Middle Aged; Phenytoin; Pulmonary Embolism; Secondary Prevention; Seizures; Treatment Outcome; Venous Thrombosis	2016
Direct oral anticoagulants in rare venous thrombosis. Internal and emergency medicine, 2016, Volume: 11, Issue:2 Topics: Anticoagulants; Dabigatran; Humans; Pyrazoles; Pyridones; Rivaroxaban; Venous Thrombosis	2016
Combined factor IIa and Xa inhibitor therapy for thrombosis whilst on therapeutic anticoagulant. Thrombosis research, 2016, Volume: 143 Topics: Adult; Aged; Anticoagulants; Antithrombins; Arginine; Dabigatran; Factor Xa Inhibitors; Female; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Neoplasms; Pipecolic Acids; Pyrazoles; Pyridones; Recurrence; Rivaroxaban; Sulfonamides; Venous Thrombosis	2016
Dabigatran can cause eosinophilic pleural and pericardial effusion with blood eosinophilia. The clinical respiratory journal, 2018, Volume: 12, Issue:2 Topics: Aged; Dabigatran; Eosinophilia; Follow-Up Studies; Humans; Male; Multimorbidity; Pleural Effusion; Severity of Illness Index; Thoracoscopy; Venous Thrombosis	2018
RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate. Thrombosis and haemostasis, 2017, 01-26, Volume: 117, Issue:2 Topics: Acute Disease; Anticoagulants; Antithrombins; Blood Coagulation; Cross-Sectional Studies; Dabigatran; Hemorrhage; Humans; Prospective Studies; Pulmonary Embolism; Research Design; Risk Factors; Time Factors; Treatment Outcome; Venous Thromboembolism; Venous Thrombosis; Vitamin K	2017
Reversal of direct oral anticoagulants for liver transplantation in cirrhosis: A step forward. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2017, Volume: 23, Issue:3 Topics: Administration, Intravenous; Administration, Oral; Antibodies, Monoclonal, Humanized; Anticoagulants; Blood Loss, Surgical; Dabigatran; End Stage Liver Disease; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Preoperative Care; Severity of Illness Index; Treatment Outcome; Venous Thrombosis	2017
Dabigatran-related leukocytoclastic vasculitis. BMJ case reports, 2017, Jan-04, Volume: 2017 Topics: Antithrombins; Dabigatran; Diagnosis, Differential; Humans; Male; Middle Aged; Vasculitis, Leukocytoclastic, Cutaneous; Venous Thrombosis	2017
Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER Journal of thrombosis and thrombolysis, 2017, Volume: 43, Issue:4 Topics: Adult; Aged; Clinical Trials as Topic; Dabigatran; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Pulmonary Embolism; Stroke; Venous Thromboembolism; Venous Thrombosis; Warfarin	2017
A Comparison of the Rate of Gastrointestinal Bleeding in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin. The American journal of gastroenterology, 2017, Volume: 112, Issue:5 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Blood Transfusion; Dabigatran; Female; Gastrointestinal Hemorrhage; Hemoglobins; Humans; Incidence; Male; Pulmonary Embolism; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Venous Thrombosis; Warfarin	2017
[Recurrent thromboembolisms despite full anticoagulation in a patient with antiphospholipid syndrome]. Der Internist, 2017, Volume: 58, Issue:7 Topics: Anticoagulants; Antiphospholipid Syndrome; Antithrombins; Dabigatran; Female; Humans; International Normalized Ratio; Lupus Erythematosus, Systemic; Partial Thromboplastin Time; Pulmonary Embolism; Recurrence; Thromboembolism; Venous Thrombosis	2017
Favorable therapeutic index of the direct factor Xa inhibitors, apixaban and rivaroxaban, compared with the thrombin inhibitor dabigatran in rabbits. Journal of thrombosis and haemostasis : JTH, 2009, Volume: 7, Issue:8 Topics: Animals; Benzimidazoles; Blood Coagulation Tests; Dabigatran; Dose-Response Relationship, Drug; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Morpholines; Pyrazoles; Pyridines; Pyridones; Rabbits; Rivaroxaban; Thiophenes; Thrombin; Venous Thrombosis	2009
Dabigatran: new drug. Continue to use heparin, a better-known option. Prescrire international, 2009, Volume: 18, Issue:101 Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Dabigatran; Drug Approval; Enoxaparin; Factor Xa Inhibitors; Fibrinolytic Agents; France; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hirudin Therapy; Humans; Prodrugs; Pyridines; Randomized Controlled Trials as Topic; Thrombin; Thromboembolism; Venous Thrombosis; Vitamin K	2009
New direct thrombin inhibitors. Internal and emergency medicine, 2009, Volume: 4, Issue:6 Topics: Atrial Fibrillation; Benzimidazoles; Dabigatran; Drugs, Investigational; Humans; Prodrugs; Pyridines; Thrombin; Venous Thrombosis	2009
New anticoagulants for the prevention of deep venous thrombosis: time to consider cost effectiveness? PharmacoEconomics, 2009, Volume: 27, Issue:10 Topics: Anticoagulants; Benzimidazoles; Clinical Trials as Topic; Cost-Benefit Analysis; Dabigatran; Economics, Pharmaceutical; Humans; Morpholines; Pyridines; Rivaroxaban; Thiophenes; Venous Thrombosis	2009
DVT: a new era in anticoagulant therapy. Arteriosclerosis, thrombosis, and vascular biology, 2010, Volume: 30, Issue:3 Topics: Animals; Anticoagulants; Benzimidazoles; Dabigatran; Disease Models, Animal; Factor Xa Inhibitors; Humans; Mice; Mice, Knockout; Morpholines; Pyridines; Rivaroxaban; Thiophenes; Thrombin; Venous Thrombosis	2010
Dabigatran offers the simplest solution for thromboprophylaxis after orthopaedic surgery in patients allergic to low-molecular-weight heparins. British journal of haematology, 2010, Volume: 151, Issue:1 Topics: Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Knee; Benzimidazoles; Dabigatran; Drug Eruptions; Female; Heparin, Low-Molecular-Weight; Humans; Postoperative Complications; Pyridines; Venous Thrombosis	2010
[Direct inhibitors of thrombin, hirudin, bivalirudin, and dabigatran etexilate]. Journal des maladies vasculaires, 2011, Volume: 36, Issue:1 Topics: Anticoagulants; Antithrombins; Benzimidazoles; Contraindications; Dabigatran; Drug Interactions; Heparin; Hirudin Therapy; Hirudins; Humans; Orthopedic Procedures; Peptide Fragments; Postoperative Complications; Pyridines; Recombinant Proteins; Thrombocytopenia; Thrombosis; Venous Thrombosis	2011
New insights on the role of direct thrombin inhibitors for the prevention of venous thromboembolism after major orthopaedic surgery. Thrombosis and haemostasis, 2011, Volume: 105, Issue:4 Topics: Anticoagulants; Antithrombins; Arthroplasty, Replacement, Hip; Benzimidazoles; beta-Alanine; Dabigatran; Enoxaparin; Humans; Postoperative Complications; Randomized Controlled Trials as Topic; Venous Thromboembolism; Venous Thrombosis	2011
Trousseau's syndrome in a patient with adenocarcinoma of unknown primary and therapy-resistant venous thrombosis treated with dabigatran and fondaparinux. British journal of clinical pharmacology, 2011, Volume: 72, Issue:4 Topics: Adenocarcinoma; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Drug Resistance; Drug Therapy, Combination; Female; Fondaparinux; Humans; Middle Aged; Neoplasms, Unknown Primary; Polysaccharides; Syndrome; Treatment Outcome; Venous Thrombosis	2011
[New treatments for venous thromboembolic disease]. Journal des maladies vasculaires, 2011, Volume: 36 Suppl 1 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Heparin; Humans; Morpholines; Pulmonary Embolism; Rivaroxaban; Secondary Prevention; Thiophenes; Venous Thrombosis; Warfarin	2011
Use of direct thrombin inhibitor for treatment of cerebral venous thrombosis. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2012, Volume: 21, Issue:8 Topics: Adult; Antithrombins; Benzimidazoles; beta-Alanine; Cerebral Angiography; Dabigatran; Humans; Intracranial Thrombosis; Magnetic Resonance Angiography; Male; Middle Aged; Off-Label Use; Phlebography; Treatment Outcome; Venous Thrombosis	2012
Dabigatran in recurrent deep vein thrombosis: when one-size does not fit all. The Israel Medical Association journal : IMAJ, 2012, Volume: 14, Issue:7 Topics: Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Male; Recurrence; Treatment Failure; Venous Thrombosis	2012
Design, synthesis, and evaluation of 2-substituted ethenesulfonic acid ester derivatives as protein tyrosine phosphatase 1B inhibitors. European journal of medicinal chemistry, 2012, Volume: 57 Topics: Adenosine Diphosphate; Animals; Benzimidazoles; Blood Platelets; Dabigatran; Drug Design; Esters; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Microsomes, Liver; Platelet Aggregation; Platelet Aggregation Inhibitors; Prodrugs; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Pyrazines; Pyridines; Rabbits; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thrombin; Venous Thrombosis	2012
New oral anticoagulants. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2013, Mar-05, Volume: 185, Issue:4 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; Canada; Contraindications; Dabigatran; Drug Dosage Calculations; Drug Interactions; Humans; Morpholines; Postoperative Complications; Pyridines; Rivaroxaban; Stroke; Thiophenes; Venous Thromboembolism; Venous Thrombosis	2013
Dabigatran vs. low molecular weight heparin in preventing venous thromboembolism after elective hip and knee arthroplasty: evaluation of selected clinical parameters. Polish orthopedics and traumatology, 2012, Oct-25, Volume: 77 Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Benzimidazoles; Dabigatran; Dose-Response Relationship, Drug; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Postoperative Complications; Pyridines; Randomized Controlled Trials as Topic; Venous Thromboembolism; Venous Thrombosis	2012
Direct thrombin inhibitors. The New England journal of medicine, 2005, Sep-08, Volume: 353, Issue:10 Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Antithrombins; Arginine; Benzimidazoles; Blood Coagulation; Dabigatran; Heart Diseases; Heparin; Humans; Pipecolic Acids; Prodrugs; Pyridines; Sulfonamides; Thrombin; Thromboembolism; Thrombosis; Venous Thrombosis	2005
Agents to control bleeding show promise. JAMA, 2007, Jan-24, Volume: 297, Issue:4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Anticoagulants; Benzimidazoles; Dabigatran; Fibrinolytic Agents; Hematologic Agents; Humans; Oligosaccharides; Pulmonary Embolism; Purpura, Thrombocytopenic, Idiopathic; Pyridines; Receptors, Thrombopoietin; Rituximab; Venous Thrombosis	2007
Antithrombotic and anticoagulant effects of the direct thrombin inhibitor dabigatran, and its oral prodrug, dabigatran etexilate, in a rabbit model of venous thrombosis. Journal of thrombosis and haemostasis : JTH, 2007, Volume: 5, Issue:6 Topics: Administration, Oral; Animals; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Dabigatran; Disease Models, Animal; Dose-Response Relationship, Drug; Fibrinolytic Agents; Heparin; Hirudin Therapy; Injections, Intravenous; Male; Partial Thromboplastin Time; Prodrugs; Pyridines; Rabbits; Venous Thrombosis	2007
Development of oral anticoagulants. British journal of clinical pharmacology, 2007, Volume: 64, Issue:3 Topics: Administration, Oral; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dabigatran; Drug Delivery Systems; Drug Design; Enoxaparin; Factor Xa Inhibitors; Humans; Morpholines; Postoperative Hemorrhage; Pyridines; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis; Warfarin	2007
Trials of venous thromboembolism prevention. Lancet (London, England), 2007, Sep-15, Volume: 370, Issue:9591 Topics: Anticoagulants; Arthroplasty, Replacement, Hip; Benzimidazoles; Dabigatran; Enoxaparin; Humans; Postoperative Complications; Pyridines; Randomized Controlled Trials as Topic; Reproducibility of Results; Venous Thrombosis	2007
[Update in hospital internal medicine (2007): a selection]. Revue medicale suisse, 2008, Jan-30, Volume: 4, Issue:142 Topics: Anti-Bacterial Agents; Anticoagulants; Benzimidazoles; Bone Density Conservation Agents; Community-Acquired Infections; Coronary Disease; Dabigatran; Defibrillators, Implantable; Diabetes Mellitus, Type 2; Fractures, Bone; Heart Failure; Heart Neoplasms; Hip Prosthesis; Hospital Departments; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Internal Medicine; Liver Cirrhosis; Oligosaccharides; Osteoporosis; Peritonitis; Pneumonia, Bacterial; Pulmonary Embolism; Pyridines; Quality of Health Care; Risk Factors; Stroke; Teaching; Tomography, X-Ray Computed; Venous Thrombosis	2008